Delivery Order SPE2DR25D2211-SPE2DR26FM4B2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $6,130.99 under a firm fixed-price arrangement, with an ultimate completion date of November 17, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $7,208.69. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units. This contract, valued at $1,605.20, is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $7,526.13. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 14, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,966.24 under a firm fixed-price arrangement, with an ultimate completion date of November 17, 2025. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $11,354.83 by the Defense Logistics Agency (DLA) on November 4, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order is set to be completed by November 5, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at approximately $29,900 on September 23, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, reflecting the contractor's ability to compete in open procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $35,990.01. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on April 24, 2025, with a ceiling value of $1,550.42 and firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of April 25, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D2211Indefinite Delivery Contract
- SPE2DR25D2211-SPE2DR26FM4B2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive award, with a ceiling value of $4,141.93, reflects a firm fixed price contract type with an ultimate completion date of November 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial valuation of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical products and medical supplies. The company's federal contract awards demonstrate extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a non-set-aside, competitively awarded contract, this delivery order exemplifies AmerisourceBergen's capability to meet federal procurement requirements efficiently while supporting the Defense Health Agency and other government healthcare systems through its flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/18/25 |